The impact of the COVID-19 pandemic on people with diabetes and diabetes services: A pan-European survey of diabetes specialist nurses undertaken by the Foundation of European Nurses in Diabetes survey consortium.


Journal

Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858

Informations de publication

Date de publication:
05 2021
Historique:
revised: 24 11 2020
received: 11 09 2020
accepted: 29 11 2020
pubmed: 15 12 2020
medline: 1 5 2021
entrez: 14 12 2020
Statut: ppublish

Résumé

To describe diabetes nurses' perspectives on the impact of the COVID-19 pandemic on people with diabetes and diabetes services across Europe. An online survey developed using a rapid Delphi method. The survey was translated into 17 different languages and disseminated electronically in 27 countries via national diabetes nurse networks. Survey responses from 1829 diabetes nurses were included in the analysis. The responses indicated that 28% (n = 504) and 48% (n = 873) of diabetes nurses felt the COVID-19 pandemic had impacted 'a lot' on the physical and psychological risks of people with diabetes, respectively. The following clinical problems were identified as having increased 'a lot': anxiety 82% (n = 1486); diabetes distress 65% (n = 1189); depression 49% (n = 893); acute hyperglycaemia 39% (n = 710) and foot complications 18% (n = 323). Forty-seven percent (n = 771) of respondents identified that the level of care provided to people with diabetes had declined either extremely or quite severely. Self-management support, diabetes education and psychological support were rated by diabetes nurse respondents as having declined extremely or quite severely during the COVID-19 pandemic by 31% (n = 499), 63% (n = 1,027) and 34% (n = 551), respectively. The findings show that diabetes nurses across Europe have seen significant increases in both physical and psychological problems in their patient populations during COVID-19. The data also show that clinical diabetes services have been significantly disrupted. As the COVID-19 situation continues, we need to adapt care systems with some urgency to minimise the impact of the pandemic on the diabetes population.

Identifiants

pubmed: 33314244
doi: 10.1111/dme.14498
pmc: PMC7883040
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14498

Subventions

Organisme : Foundation of European Nurses in Diabetes

Investigateurs

Maya Allen-Taylor (M)
Freya Brown (F)
Aycan Celick (A)
Sarah Gane (S)
Rabab Hashem (R)
Hellena Habete-Asres (H)
Qinxiu Tian (Q)
Jackie Sturt (J)
Kirsty Winkley (K)
Rudi Caron (R)
Snježana Gaćina (S)
Yvonne Moloney (Y)
Ewa Kobos (E)
Margarida Jansà (M)
Carmen Yoldi (C)

Informations de copyright

© 2020 Diabetes UK.

Références

Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550
pubmed: 32334646
Diabetes Obes Metab. 2020 Oct;22(10):1935-1941
pubmed: 32314455
Diabet Med. 2020 Jul;37(7):1146-1154
pubmed: 32392380
Pediatr Diabetes. 2020 Nov;21(7):1083-1092
pubmed: 32686287
Medicine (Baltimore). 2018 Oct;97(43):e12962
pubmed: 30412116
Telemed J E Health. 2019 Jul;25(7):569-583
pubmed: 30124394
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
N Engl J Med. 2020 Aug 20;383(8):789-790
pubmed: 32530585
Diabetes Res Clin Pract. 2020 Apr;162:108142
pubmed: 32278764
Diabetes Care. 2020 Aug;43(8):1704-1709
pubmed: 32532755
J Diabetes Complications. 2020 Sep;34(9):107621
pubmed: 32425465
Diabet Med. 2020 Jul;37(7):1087-1089
pubmed: 32365233
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792
pubmed: 32687793
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):965-967
pubmed: 32604016
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833
pubmed: 32798471

Auteurs

Rita Forde (R)

King's College London, London, UK.

Liga Arente (L)

Riga East University Hospital, Riga, Latvia.

Davide Ausili (D)

University of Milano-Bicocca, Monza, Italy.

Kristin De Backer (K)

University Hospital Antwerp, Edegem, Belgium.

Mette Due-Christensen (M)

King's College London, London, UK.
Steno Diabetes Centre Copenhagen, Gentofte, Denmark.

Amanda Epps (A)

Medway NHS Foundation Trust, Gillingham, UK.

Anne Fitzpatrick (A)

St Michael's Hospital, Dublin, Ireland.

Moira Grixti (M)

Health-Mater Dei Hospital, Msida, Malta.

Sijda Groen (S)

Albert Schweitzer, Dordrecht, The Netherlands.

Arja Halkoaho (A)

Tampere University of Applied Sciences, Tampere, Finland.

Claudia Huber (C)

HES-SO Haute école de santé Fribourg Switzerland, Fribourg, Switzerland.

Marjolein M Iversen (MM)

Western Norway University of Applied Sciences, Bergen, Norway.

Unn-Britt Johansson (UB)

Sophiahemmet University College Stockholm, Stockholm, Sweden.
Karolinska Institute, Stockholm, Sweden.

Claudia Leippert (C)

VDBD, Berlin, Germany.

Seyda Ozcan (S)

Koc University, Istanbul, Turkey.

Julie Parker (J)

Gibraltar Health Authority, Gibraltar.

Ana Christina Paiva (AC)

Portuguese Diabetes Association, Lisbon, Portugal.

Adina Sanpetreanu (A)

Cluj-Napoca Diabetes Centre and Clinic, Cluj-Napoca, Romania.

Marie-Alice Savet (MA)

Geneva University Hospital, Geneva, Switzerland.

Svetic-Cisic Rosana (SC)

Consultecca, Zagreb, Croatia.

Alicja Szewczyk (A)

The Children's Memorial Health Institute, Warsaw, Poland.

Maite Valverde (M)

Hospital Mútua Terrassa, Terrassa, Spain.

Eugenia Vlachou (E)

University of West Attica, Athens, Greece.

Angus Forbes (A)

King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH